Rott Roland 4
4 · GE HealthCare Technologies Inc. · Filed Sep 12, 2025
Insider Transaction Report
Form 4
Rott Roland
CEO, Imaging
Transactions
- Tax Payment
Common Stock, par value $0.01 per share
2025-09-11$76.68/sh−1,352$103,671→ 29,122 total - Exercise/Conversion
Employee Stock Option (right to buy)
2025-09-11−3,727→ 0 totalExercise: $57.74Exp: 2029-03-19→ Common Stock, par value $0.01 per share (3,727 underlying) - Tax Payment
Common Stock, par value $0.01 per share
2025-09-11$76.68/sh−3,268$250,590→ 28,860 total - Exercise/Conversion
Employee Stock Option (right to buy)
2025-09-11−1,614→ 0 totalExercise: $51.67Exp: 2029-04-11→ Common Stock, par value $0.01 per share (1,614 underlying) - Exercise/Conversion
Common Stock, par value $0.01 per share
2025-09-11$57.74/sh+3,727$215,197→ 32,128 total - Exercise/Conversion
Common Stock, par value $0.01 per share
2025-09-11$51.67/sh+1,614$83,395→ 30,474 total
Footnotes (2)
- [F1]Represents the number of shares withheld by GE HealthCare Technologies Inc. ("GE HealthCare") to satisfy the exercise price and tax withholding obligations in connection with the net settlement of the options, and does not represent a sale of any shares by the Reporting Person.
- [F2]Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023, of the distribution of approximately 80.1% of the shares of GE HealthCare common stock by GE to holders of GE common stock on a pro-rata basis, of which 100% was fully exercisable immediately.